Janssen Biotech (Johnson & Johnson)
Balversa is a prescription medicine used to treat adults with bladder cancer that has spread or cannot be removed by surgery.
The cancer targeted by the medication has a certain type of abnormal fibroblast growth factor receptor (FGFR) gene for patients who have tried at least one other chemotherapy medicine that contains platinum that didn’t work or is no longer working.
Balversa’s most common side effects include mouth sores, feeling tired, change in kidney function, diarrhea, dry mouth, nail separate from the bed or poor formation of the nail, low salt levels, change in liver function, decreased appetite, change in sense of taste, low red blood cells, dry skin, dry eyes, hair loss, redness, swelling, peeling or tenderness on the hands and feet, constipation, stomach pain, nausea and muscle pain.
Filed Under: Drug Discovery, Drug Discovery and Development, Neurological Disease, Oncology, Orphan Drugs